agilon health (NYSE:AGL) Trading 5% Higher - What's Next?

agilon health, inc. (NYSE:AGL - Get Free Report)'s share price rose 5% on Wednesday . The company traded as high as $2.11 and last traded at $2.10. Approximately 983,073 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 4,839,103 shares. The stock had previously closed at $2.00.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. JMP Securities downgraded agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, November 11th. Evercore ISI lowered their price target on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a report on Tuesday, October 8th. Citigroup decreased their price objective on shares of agilon health from $2.50 to $1.75 and set a "sell" rating for the company in a research report on Wednesday, November 13th. TD Cowen dropped their target price on shares of agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a report on Monday, November 11th. Finally, Bank of America downgraded agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target for the company. in a report on Wednesday, October 2nd. Three equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $4.28.

agilon health Trading Down 2.5 %

The firm has a market cap of $803.44 million, a price-to-earnings ratio of -2.07 and a beta of 0.51. The firm's 50-day moving average is $2.37 and its 200-day moving average is $4.30. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period last year, the business posted ($0.06) earnings per share. As a group, sell-side analysts anticipate that agilon health, inc. will post -0.52 EPS for the current fiscal year.

Insider Buying and Selling at agilon health

In related news, Director Karen Mcloughlin acquired 25,000 shares of the company's stock in a transaction on Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company's stock.

Institutional Investors Weigh In On agilon health

Several institutional investors and hedge funds have recently added to or reduced their stakes in AGL. AQR Capital Management LLC boosted its stake in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock worth $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC boosted its position in agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock worth $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Citigroup Inc. grew its stake in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new position in agilon health in the 2nd quarter valued at $1,849,000. Finally, Bank of New York Mellon Corp increased its position in shares of agilon health by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company's stock valued at $7,252,000 after purchasing an additional 174,883 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.